|
2025 Conference Publication Improving clinical efficiency using retrieval-augmented generation in urologic oncology: A guideline-enhanced AI approachRoberts, Matthew, Keogh, Kandice, Siriwardana, Amila and Basto, Marnique (2025). Improving clinical efficiency using retrieval-augmented generation in urologic oncology: A guideline-enhanced AI approach. USANZ 77th Annual Scientific Meeting, Perth, WA, Australia, 1-4 March 2025. Chichester, West Sussex, United Kingdom: Wiley-Blackwell. |
|
2025 Conference Publication Transperineal prostate biopsy under local versus general anaesthesia: a cost-effectiveness analysisRoberts, Matthew, Arora, Shiksha, Yao, Henry, Hogan, Donnacha, Dias, Brendan, O'Connell, Helen, Wetherell, David, Zargar, Homayoun, Pearce, Adam, Yaxley, John and Tuffaha, Haitham (2025). Transperineal prostate biopsy under local versus general anaesthesia: a cost-effectiveness analysis. USANZ 77th Annual Scientific Meeting, Perth, WA Australia, 1-4 March 2025. Chichester, West Sussex United Kingdom: Wiley-Blackwell. |
|
2025 Conference Publication Lymph node metastasis on PSMA PET as a predictor of PSA relapse and imaging progression after radical prostatectomy and pelvic lymph node dissectionTran, Elisa, Coughlin, Geoff, Yaxley, John, Samaratunga, Hema and Roberts, Matthew (2025). Lymph node metastasis on PSMA PET as a predictor of PSA relapse and imaging progression after radical prostatectomy and pelvic lymph node dissection. USANZ 77th Annual Scientific Meeting, Perth, WA, Australia, 1-4 March 2025. Chichester, West Sussex, United Kingdom: Wiley-Blackwell. |
|
2025 Conference Publication Non-invasive detection of significant prostate cancer with a 3-gene urine testRoberts, Matthew, Koo, Kevin, Yaxley, John, Samaratunga, Hema, Jones, Andrew, Trau, Matt and Gardiner, Frank (2025). Non-invasive detection of significant prostate cancer with a 3-gene urine test. 77th Annual Scientific Meeting of the Urological-Society-of-Australia-and-New Zealand, Perth, WA Australia, 1-4 March 2025. Chichester, West Sussex, United Kingdom: Wiley. |
|
2025 Conference Publication Transfusion-dependence predicts poor outcomes following hyperbaric oxygen treatment for radiation cystitis: a single tertiary centre retrospective analysisJoshi, Sachin, Loganathan, Ajanthan, Dunglison, Nigel, Esler, Rachel, Martin, Benjamin, Llewellyn, Stacey, Thistlethwaite, Kenneth and Roberts, Matthew (2025). Transfusion-dependence predicts poor outcomes following hyperbaric oxygen treatment for radiation cystitis: a single tertiary centre retrospective analysis. USANZ 77th Annual Scientific Meeting, Perth, WA, Australia, 1-4 March 2025. Chichester, West Sussex, United Kingdom: Wiley-Blackwell. |
|
2024 Conference Publication The cost-effectiveness of germline BRCA testing in prostate cancer followed by cascade testing of first-degree relatives of mutation carriersTeppala, S., Scuffham, P., Edmunds, K., Roberts, M., Fairbairn, D., Smith, D., Horvath, L. and Tuffaha, H. (2024). The cost-effectiveness of germline BRCA testing in prostate cancer followed by cascade testing of first-degree relatives of mutation carriers. ISPOR Europe 2024: Generating Evidence Toward Health and Well-Being, Barcelona, Spain, 17-20 November 2024. New York, United States: Elsevier. doi: 10.1016/j.jval.2024.10.610 |
|
2024 Conference Publication The cost-effectiveness of targeted germline BRCA testing in localised prostate cancer followed by cascade testing of first-degree relatives of mutation carriersTeppala, Srinivas, Scuffham, Paul, Edmunds, Kim, Roberts, Matthew, Fairbairn, David, Smith, David, Horvath, Lisa and Tuffaha, Haitham (2024). The cost-effectiveness of targeted germline BRCA testing in localised prostate cancer followed by cascade testing of first-degree relatives of mutation carriers. COSA's 51st Annual Scientific Meeting Bridging gaps, building progress, breaking down disparities, Gold Coast, QLD Australia, 13–15 November 2024. Richmond, VIC Australia: John Wiley & Sons. |
|
2024 Conference Publication The early oncological effect of extended pelvic lymph node dissection in men with at PSMA PET/CT N0M0 intermediate/high-risk prostate cancer - an international cohort studyVan Leeuwen, P.J., Berrens, A-C., Vis, A., Yaxley, J., Meijer, D., Siriwardana, A., Wit, E., Van Der Noort, V., Morton, A., Franklin, A., Yaxley, J., Wong, D., Goughlin, G., Gianduzzo, T., Kua, B., Emmett, L., Zuur, L., Van Der Poel, H. and Roberts, M. (2024). The early oncological effect of extended pelvic lymph node dissection in men with at PSMA PET/CT N0M0 intermediate/high-risk prostate cancer - an international cohort study. EAU24 - 39th Annual EAU Congress, Paris, France, 5-8 April 2024. Amsterdam, Netherlands: Elsevier. doi: 10.1016/s0302-2838(24)01002-9 |
|
2024 Conference Publication Combining MRI PI-RADS and PSMA-PET/CT PRIMARY score in a composite (P) score for more accurate diagnosis of clinically significant prostate cancerEmmett, L., Papa, N., Hope, T., Fendler, W., Calais, J., Burger, I., Eiber, M., Barbato, F., Moon, D., Xue, A., Franklin, A., Thompson, J., Rasiah, K., Frydenberg, M., Yaxley, J., Buteau, J., Liu, V., Nguyen, A., Hsiao, E., Stricker, P., Hofman, M., Kasivisvanathan, V., Roberts, M. and Murphy, D. (2024). Combining MRI PI-RADS and PSMA-PET/CT PRIMARY score in a composite (P) score for more accurate diagnosis of clinically significant prostate cancer. EAU24 - 39th Annual EAU Congress, Paris, France, 5-8 April 2024. Amsterdam, Netherlands: Elsevier. doi: 10.1016/s0302-2838(24)00417-2 |
|
2024 Conference Publication Early oncological outcomes following radical prostatectomy of patients with pelvic lymph node-positive prostate cancer at preoperative PSMA PET/CTZuur, L.G., de Bie, K., Vis, A.N., Van Der Poel, H.G., Donswijk, M.L., Oprea-Lager, D.E., Roberts, M. and Van Leeuwen, P.J. (2024). Early oncological outcomes following radical prostatectomy of patients with pelvic lymph node-positive prostate cancer at preoperative PSMA PET/CT. EAU24 - 39th Annual EAU Congress, Paris, France, 5-8 April 2024. Amsterdam, Netherlands: Elsevier. doi: 10.1016/s0302-2838(24)01187-4 |
|
2024 Conference Publication Development and external validation of a novel nomogram to predict the probability of pelvic lymph-node metastases in prostate cancer patients using magnetic resonance imaging and molecular imaging with prostate-specific membrane antigen positron emissionVis, A., Meijer, D., Roberts, M.J., Siriwardana, A.R., Morton, A., Yaxley, J.W., Samaratunga, H., Emmett, L., Van Der Ven, P.M., Heymans, M.W., Nieuwenhuijzen, J.A., Van Der Poel, H.G., Van Donswijk, M.L., Boellaard, T.N., Schoots, I.G., Stricker, P., Haynes, A-M., Oprea-Lager, D.E., Coughlin, G.D. and Van Leeuwen, P.J. (2024). Development and external validation of a novel nomogram to predict the probability of pelvic lymph-node metastases in prostate cancer patients using magnetic resonance imaging and molecular imaging with prostate-specific membrane antigen positron emission. EAU24 - 39th Annual EAU Congress, Paris, France, 5-8 April 2024. Amsterdam, Netherlands: Elsevier. doi: 10.1016/s0302-2838(24)00422-6 |
|
2023 Conference Publication Quality of health information in ChatGPT responses to common patient enquiries about recurrent UTI treatment and preventionCollin, Harry and Roberts, Matthew (2023). Quality of health information in ChatGPT responses to common patient enquiries about recurrent UTI treatment and prevention. Annual Scientific Meeting of the Singapore-Urological-Association (SUA), Singapore, 6-8 July 2023. Chichester, West Sussex, United Kingdom: Wiley-Blackwell. |
|
2023 Conference Publication Virtual healthcare delivery in urology - is AI the future for patient information on prostate cancer?Collin, Harry and Roberts, Matthew (2023). Virtual healthcare delivery in urology - is AI the future for patient information on prostate cancer?. Annual Scientific Meeting of the Singapore-Urological-Association (SUA), Singapore, 6-8 July 2023. Chichester, West Sussex, United Kingdom: Wiley-Blackwell. |
|
2023 Conference Publication Lu-PSMA Therapy - Practical considerations for urologistsCollin, Harry, Keogh, Kandice and Roberts, Matthew (2023). Lu-PSMA Therapy - Practical considerations for urologists. 2023 ANZUP Annual Scientific Meeting, Bouncing Back, Melbourne, VIC, Australia, 9-11 July 2023. Hoboken, NJ, United States: Wiley. |
|
2023 Conference Publication PRIMARY2 Trial Protocol: Phase III, multicentre, randomised controlled trial investigating the additive diagnostic value of [68Ga]Ga-PSMA-11 PET/CT in men with negative/equivocal MRI in the diagnosis of clinically significant prostate cancerButeau, James, Moon, Daniel, Fahey, Michael, Roberts, Matthew, Thompson, James, Murphy, Declan G., Papa, Nathan, Mitchell, Catherine, Kasivisvanathan, Veeru, Stricker, Phillip, O'Brien, Jonathan, Counter, William, Sharma, Gaurav, Agrawal, Shikha, Ho, Bao, Dilulio, Juliana, Lindeman, William, De Abreu, Lourenco Richard, Dhillon, Haryana M., Hofman, Michael S. and Emmett, Louise (2023). PRIMARY2 Trial Protocol: Phase III, multicentre, randomised controlled trial investigating the additive diagnostic value of [68Ga]Ga-PSMA-11 PET/CT in men with negative/equivocal MRI in the diagnosis of clinically significant prostate cancer. 2023 ANZUP Annual Scientific Meeting, Bouncing Back, Melbourne, VIC, Australia, 9-11 July 2023. Hoboken, NJ, United States: Wiley. |
|
2023 Conference Publication Can artificial intelligence devise surveillance regimens for testicular cancer?Collin, Harry, Keogh, Kandice and Roberts, Matthew (2023). Can artificial intelligence devise surveillance regimens for testicular cancer?. 2023 ANZUP Annual Scientific Meeting, Bouncing Back, Melbourne, VIC, Australia, 9-11 July 2023. Hoboken, NJ, United States: Wiley. |
|
2023 Conference Publication Dr Bot - Does AI provide quality information to prostate cancer patients?Collin, Harry, Keogh, Kandice and Roberts, Matthew (2023). Dr Bot - Does AI provide quality information to prostate cancer patients?. 2023 ANZUP Annual Scientific Meeting, Bouncing Back, Melbourne, VIC, Australia, 9-11 July 2023. Hoboken, NJ, United States: Wiley. |
|
2023 Conference Publication Initial diagnostic accuracy of FDG-PET compared to PSMA-PET for newly diagnosed high risk prostate cancer prior to treatment: FIND TrialRoberts, Matthew, Roberts, Natasha, Harley, Simon, Cullen, Karla, Pelecanos, Anita, Vela, Ian, Yaxley, John, Kuchel, Anna, Dhiantravan, Nattakorn, Thomas, Paul and Pattison, David (2023). Initial diagnostic accuracy of FDG-PET compared to PSMA-PET for newly diagnosed high risk prostate cancer prior to treatment: FIND Trial. 2023 ANZUP Annual Scientific Meeting, Bouncing Back, Melbourne, VIC, Australia, 9-11 July 2023. Hoboken, NJ, United States: Wiley. |
|
2023 Conference Publication Adding mitomycin (MM) to bacillus Calmette-Guerin (BCG) as adjuvant intravesical therapy for high-risk, non-muscle-invasive urothelial bladder cancer (NMIBC)Hayne, Dickon, Stockler, Martin R., Martin, Andrew James, McCombie, Steve P., Zebic, Danka Sinikovic, Bastick, Patricia A., Beardsley, Emma Kate, Frydenberg, Mark, Green, William, Grummet, Jeremy, Hawks, Cynthia, Ischia, Joseph, Mitterdorfer, Andrew, Patel, Manish, Roberts, Matthew, Sengupta, Shomik, Srivastav, Ratnesh Kumar, Redfern, Andrew David and Davis, Ian D. (2023). Adding mitomycin (MM) to bacillus Calmette-Guerin (BCG) as adjuvant intravesical therapy for high-risk, non-muscle-invasive urothelial bladder cancer (NMIBC). Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Chicago, IL USA, 2-6 June 2023. Philadelphia, PA USA: Lippincott Williams & Wilkins. doi: 10.1200/JCO.2023.41.16_suppl.TPS4617 |
|
2023 Conference Publication PRIMARY2: A phase III, multi-centre, randomised controlled trial investigating the additive diagnostic value of [<sup>68</sup>Ga]Ga-PSMA-11 PET/CT in men with negative/equivocal MRI in the diagnosis of clinically significant prostate cancerButeau, James Patrick, Moon, Daniel, Fahey, Michael T., Roberts, Matthew, Thompson, James, Murphy, Declan G., Papa, Nathan, Mitchell, Catherine, Kasivisvanathan, Veeru, Stricker, Phillip, O'Brien, Jonathan, Counter, William, Sharma, Gaurav, Agrawal, Shikha, Ho, Bao, Yeung, Theresa, Lourenco, Richard De Abreu, Dhillon, Haryana M., Hofman, Michael S. and Emmett, Louise (2023). PRIMARY2: A phase III, multi-centre, randomised controlled trial investigating the additive diagnostic value of [68Ga]Ga-PSMA-11 PET/CT in men with negative/equivocal MRI in the diagnosis of clinically significant prostate cancer. Genitourinary Cancers Symposium, Electr Network, 16-18 February 2023. Alexandria, VA, United States: American Society of Clinical Oncology. doi: 10.1200/JCO.2023.41.6_suppl.TPS397 |
